French 2019 Budget A Mix Of Good And Bad News For Pharma
The French government is proposing to extend the use of the temporary use authorization system for unapproved drugs and to increase the rate of generic prescribing. It has also set a low threshold for the increase in pharmaceutical sales that triggers the payback mechanism.
You may also be interested in...
A French government/industry discussion forum has come up with concrete plans for accelerating access to innovative medicines by streamlining clinical trial approval and price negotiations.
Hungary is going its own way when it comes to coronavirus vaccines, but its decision to allow the emergency use of the Oxford University/AstraZeneca vaccine may be only a symbolic expression of the government’s growing impatience with the EU.
Valneva is scaling up manufacture of its coronavirus vaccine alongside the clinical development program, with a view to meeting its commitment to provide millions of doses for use in the UK and the EU.